Similarly, we found altered matrix composition in the new periosteal and perilacunar bone in our rat model of CKD, and lowering PTH with calcimimetics only partially corrected these changes,24 a finding that supports factors other than PTH affecting osteocytes. This evidence concerns the gene PTH and chronic kidney disease.